Acasti Pharma Inc (ACST)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Acasti Pharma Inc (ACST) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013144
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Acasti Pharma Inc (Acasti), a subsidiary of Neptune Technologies & Bioressources Inc is a biopharmaceutical company that offers research, development and commercialization of prescription drugs. The company offers products such as Onemia and CaPre. Its CaPre is developed for the prevention and treatment of cardiometabolic disorders including, hypertriglyceridemia. Acasti’s Onemia is an active ingredient used for clinical dietary management of cardiometabolic disorders. The company’s products are used in the therapeutic areas of hyperlipidemia, atherosclerosis, diabetes, rheumatoid arthritis, and gastroenterology disorders. It conducts market research studies through collaborations with KOLs, high volume prescribers and pharmacies. Acasti is headquartered in Laval, Quebec, Canada.

Acasti Pharma Inc (ACST) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Acasti Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Acasti Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Acasti Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Acasti Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Acasti Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Acasti Pharma Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Acasti Pharma to Enter into Agreement with China-Based Pharmaceutical Company 10
Xymogen Enters Into Distribution Agreement With Acasti Pharm For LipiChol540 11
Equity Offering 12
Acasti Pharma Files Registration Statement to Raise of up to USD17.2 Million in Public Offering of Shares 12
Acasti Pharma Raises USD4.3 Million in Public Offering of Units 13
Acasti Pharma Prices Public Offering of Units for Upto USD6 Million 15
Acasti Pharma Completes Private Placement Of Units For US$2 Million 17
Acasti Pharma Completes Public Offering Of Units For US$23 Million 18
Acasti Pharma Completes Private Placement Of Units For US$1 Million 20
Acasti Pharma Completes Private Placement Of Shares For US$1 Million 21
Acasti Pharma Completes Rights Offering Of Common Stock For US$8.3 Million 22
Debt Offering 23
Acasti Pharma Raises USD1.5 Million in Private Placement of 8% Debentures and Warrants Due 2020 23
Acasti Pharma Inc – Key Competitors 25
Acasti Pharma Inc – Key Employees 26
Acasti Pharma Inc – Locations And Subsidiaries 27
Head Office 27
Recent Developments 28
Financial Announcements 28
Aug 14, 2017: Acasti Pharma Reports First Quarter FY 2018 Financial Results 28
Jun 06, 2017: Acasti Pharma Reports Fourth Quarter and Full-Year 2017 Financial Results 29
Jan 12, 2017: Acasti Pharma Reports Third Quarter 2017 Financial Results 31
Oct 11, 2016: Acasti Pharma Reports Second Quarter 2017 Financial Results 32
Jul 11, 2016: Acasti Announces First Quarter Results 33
May 25, 2016: Acasti Pharma Announces Fourth Quarter and Fiscal Year Results 34
Jan 12, 2016: Acasti Announces Third Quarter Results 35
Corporate Communications 36
Nov 16, 2017: Acasti Pharma Announces the Election of Its Directors 36
Nov 28, 2016: Acasti Pharma names CFO 37
May 12, 2016: Jan D’Alvise Appointed President & CEO of Acasti Pharma 38
Mar 25, 2016: Nasdaq Grants Acasti Cure Period to Regain Compliance with Audit Committee Membership Requirements 39
Mar 01, 2016: Acasti Announces Management Appointment and Changes to the Board of Directors 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Tables
Acasti Pharma Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Acasti Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Acasti Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Acasti Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Acasti Pharma Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Acasti Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Acasti Pharma to Enter into Agreement with China-Based Pharmaceutical Company 10
Xymogen Enters Into Distribution Agreement With Acasti Pharm For LipiChol540 11
Acasti Pharma Files Registration Statement to Raise of up to USD17.2 Million in Public Offering of Shares 12
Acasti Pharma Raises USD4.3 Million in Public Offering of Units 13
Acasti Pharma Prices Public Offering of Units for Upto USD6 Million 15
Acasti Pharma Completes Private Placement Of Units For US$2 Million 17
Acasti Pharma Completes Public Offering Of Units For US$23 Million 18
Acasti Pharma Completes Private Placement Of Units For US$1 Million 20
Acasti Pharma Completes Private Placement Of Shares For US$1 Million 21
Acasti Pharma Completes Rights Offering Of Common Stock For US$8.3 Million 22
Acasti Pharma Raises USD1.5 Million in Private Placement of 8% Debentures and Warrants Due 2020 23
Acasti Pharma Inc, Key Competitors 25
Acasti Pharma Inc, Key Employees 26

★海外企業調査レポート[Acasti Pharma Inc (ACST)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Precision Therapeutics Inc (AIPT):医療機器:M&Aディール及び事業提携情報
    Summary Precision Therapeutics Inc (Precision Therapeutics), a joint venture between Skyline Medical and Helomics, is a medical device company. The company’s business divisions include artificial intelligence to personalized medicine and drug discovery; and system for automated, direct-to-drain medi …
  • Kuwait Petroleum International Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Kuwait Petroleum International Ltd (KPI), a subsidiary of Kuwait Petroleum Corporation, is a downstream energy company. It carries out refining of crude oil, production and marketing of refined petroleum products. The company operates refinery in Milazzo, Italy, and has retail service statio …
  • Gemalto N.V. (GTO):企業の財務・戦略的SWOT分析
    Gemalto N.V. (GTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Aptevo Therapeutics Inc (APVO):企業の財務・戦略的SWOT分析
    Aptevo Therapeutics Inc (APVO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • NBN Co Ltd:企業の戦略的SWOT分析
    NBN Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Aon plc:企業のM&A・事業提携・投資動向
    Aon plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Aon plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • Babcock & Wilcox Enterprises Inc (BW):企業の財務・戦略的SWOT分析
    Babcock & Wilcox Enterprises Inc (BW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Springs Global Participacoes S.A.:企業の戦略・SWOT・財務情報
    Springs Global Participacoes S.A. - Strategy, SWOT and Corporate Finance Report Summary Springs Global Participacoes S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Bilfinger SE:企業のM&A・事業提携・投資動向
    Bilfinger SE - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bilfinger SE Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • The Broad Institute Inc-医療機器分野:企業M&A・提携分析
    Summary The Broad Institute Inc (Broad Institute), a subsidiary of The Broad Foundation is a non-profit research organization that conducts genomic research for treatment of human diseases. The organization transforms medicine by utilizing systematic approaches in biological sciences, to speed up th …
  • Senior Housing Properties Trust:企業の戦略・SWOT・財務情報
    Senior Housing Properties Trust - Strategy, SWOT and Corporate Finance Report Summary Senior Housing Properties Trust - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Sharjah Electricity & Water Authority:企業の戦略的SWOT分析
    Sharjah Electricity & Water Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • HCL Technologies Ltd (HCLTECH):企業の財務・戦略的SWOT分析
    HCL Technologies Ltd (HCLTECH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Taiwan High Speed Rail Corporation:企業の戦略・SWOT・財務情報
    Taiwan High Speed Rail Corporation - Strategy, SWOT and Corporate Finance Report Summary Taiwan High Speed Rail Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Luxembourg Institute of Health:製薬・医療:M&Aディール及び事業提携情報
    Summary Luxembourg Institute of Health (LIH), formerly Centre de Recherche Public de la Sante is a biomedical research organisation that offers pre-clinical and clinical research in the areas of biomedicine and healthcare. The organization offers research under various departments such as infection …
  • Fitbit Inc.:企業の戦略・SWOT・財務情報
    Fitbit Inc. - Strategy, SWOT and Corporate Finance Report Summary Fitbit Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Merit Medical Systems Inc (MMSI)-医療機器分野:企業M&A・提携分析
    Summary Merit Medical Systems, Inc. (Merit Medical) offers a wide range of single-use medical devices for interventional and diagnostic procedures. The company’s products include inflation devices and accessories, diagnostic and therapeutic catheters, diagnostic and hydrophilic products, thrombolyti …
  • Sumitomo Corporation (8053):企業の財務・戦略的SWOT分析
    Sumitomo Corporation (8053) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Philips Healthcare-医療機器分野:企業M&A・提携分析
    Summary Philips Healthcare, formerly Philips Medical Systems, undertakes the manufacture and distribution of diagnostic imaging systems, healthcare information technology solutions, patient monitoring and cardiac devices. Philips Healthcare is a division of Royal Philips Electronics of the Netherlan …
  • National Power Corporation:企業の戦略的SWOT分析
    National Power Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆